Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 403,450 shares at $85.98 ($35.1M) on 2021-06-11, disclosed to the SEC on 2021-06-15.
Open-market sale of $35.1M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.18 | 29,071 | $2.5M | 7.1% |
| 2 | $85.18 | 29,071 | $2.5M | 7.1% |
| 3 | $85.98 | 1,875 | $161K | 0.5% |
| 4 | $85.98 | 1,875 | $161K | 0.5% |
| 5 | $85.92 | 16,293 | $1.4M | 4.0% |
| 6 | $85.92 | 16,293 |
| $1.4M |
| 4.0% |
| 7 | $86.73 | 47,422 | $4.1M | 11.7% |
| 8 | $86.73 | 47,422 | $4.1M | 11.7% |
| 9 | $87.75 | 93,102 | $8.2M | 23.3% |
| 10 | $87.75 | 93,102 | $8.2M | 23.3% |
| 11 | $88.70 | 13,309 | $1.2M | 3.4% |
| 12 | $88.70 | 13,309 | $1.2M | 3.4% |
| 13 | $89.25 | 653 | $58K | 0.2% |
| 14 | $89.25 | 653 | $58K | 0.2% |
| Total | $87.04 avg | 403,450 | $35.1M | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |